Acute hemolytic transfusion reaction (AHTR) is a serious and potentially life-threatening complication of blood transfusion. Diagnosis of AHTR is made based on clinical suspicion and laboratory testing.
Clinical Suspicion
AHTR can occur as soon as 15 minutes after a transfusion, or up to 5 days later. Common clinical signs of AHTR include fever, chills, chest pain, dyspnea, hypotension, back pain, abdominal pain, and dark urine.
Laboratory Testing
Laboratory testing is necessary to confirm the diagnosis of AHTR. The most important laboratory tests to order are a complete blood count (CBC), a peripheral blood smear, and a direct antiglobulin test (DAT).
The CBC will show decreased hemoglobin and hematocrit levels as well as an increased reticulocyte count. The peripheral blood smear will show hemolyzed red blood cells. The DAT is an immunoassay test that detects antibodies bound to red blood cells. A positive DAT is indicative of AHTR. Other laboratory tests may be ordered to assess the severity of the reaction, such as a lactate dehydrogenase (LDH) and haptoglobin levels.
Conclusion
AHTR is a serious and potentially life-threatening complication of blood transfusion. Diagnosis of AHTR is made based on clinical suspicion and laboratory testing, including a CBC, peripheral blood smear, and DAT. Other laboratory tests may be ordered to assess the severity of the reaction.